SERVICIO ANDALUZ DE SALUD

Their core work

SAS is the public health service of Andalusia, Spain's most populous region, operating a network of hospitals and primary care centers serving over 8 million people. In EU research, they contribute real-world clinical environments, patient cohorts, and health data infrastructure to projects spanning chronic disease management, digital health tools, antimicrobial resistance, and rare diseases. They bring the perspective of a large-scale healthcare provider to research consortia — testing interventions in actual clinical settings rather than labs. Their growing role in health data interoperability and FAIR data principles positions them as a key partner for projects requiring access to diverse, large-scale patient populations.

What they specialise in

How they've shifted over time

In the early period (2015–2018), SAS focused heavily on clinical interventions — stem cell therapies, smoking cessation, dementia support, and heart failure monitoring — acting as a clinical trial site for patient-facing health technologies. From 2019 onward, their portfolio shifted markedly toward health data infrastructure, interoperability standards (FAIR, IDMP), and large-scale infectious disease preparedness, with their two biggest-ever projects (ECRAID-Base and REVERSE, both EUR 2.5M+) addressing antimicrobial resistance. This evolution reflects a transition from testing individual digital health tools to building the data and organizational infrastructure needed for pan-European health research.

SAS is rapidly scaling up in antimicrobial resistance research and federated health data systems, making them an increasingly valuable partner for large-scale infectious disease and health data projects.

How they like to work

SAS overwhelmingly operates as a consortium partner (30 of 31 projects), contributing clinical sites, patient access, and healthcare system expertise rather than leading project design. They coordinated only one project (FAIR4Health), suggesting they prefer to plug into existing consortia rather than bear administrative coordination burdens. With 476 unique partners across 46 countries, they are a well-connected hub — comfortable working in large, multi-national consortia typical of health research.

SAS has collaborated with 476 distinct partners across 46 countries, making them one of the most broadly connected health service providers in H2020. Their network spans all of Europe and extends to Latin America (via SELNET), reflecting the global reach of the clinical research consortia they join.

What sets them apart

Unlike university hospitals that contribute primarily research capacity, SAS brings the perspective and infrastructure of an entire regional health system — with real-world clinical workflows, diverse patient populations, and procurement authority. Their combination of clinical trial experience, health data interoperability work, and pre-commercial procurement expertise is unusual for a public health service. For consortium builders, SAS offers something hard to find: a single partner that can validate health technologies in routine clinical practice across primary care, hospitals, and emergency services.

Highlights from their portfolio

• FAIR4Health
  The only project SAS coordinated — focused on FAIR data principles for health research, signaling their strategic ambition in health data governance.
• ECRAID-Base
  Their largest single grant (EUR 2.5M) building a pan-European clinical research alliance for infectious diseases and outbreak preparedness.
• REVERSE
  Second-largest grant (EUR 2.5M) tackling antimicrobial resistance prevention in high-prevalence settings — reflects their pivot to AMR as a major focus.